A question with respect to asthma therapy revolves around the issue of whether better efficacy occurs with an ultrafine-particle inhaled corticosteroid because of better lung deposition into the distal airways. This article reviews particle size and delivery devices of different steroids, clinical outcomes of small- versus large-particle steroids, and the issue of pharmacoeconomics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaci.2009.09.050 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!